Shares of Health Care sector company ResMed moved -6.3% today, and are now trading at a price of $190.7. The Large-Cap stock's daily volume was 2,153,599 compared to its average volume of 1,198,390. The S&P 500 index returned a 0.0% performance.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company is based in San Diego and has 10,600 full time employees. Its market capitalization is $27,662,252,032. ResMed currently offers its equity investors a dividend that yields 1.1% per year.
15 analysts are following ResMed and have set target prices ranging from $180.0 to $340.0 per share. On average, they have given the company a rating of buy. At today's prices, RMD is trading -29.53% away from its average analyst target price of $270.6 per share.
Over the last year, RMD shares have gone down by -16.9%, which represents a difference of -44.8% when compared to the S&P 500. The stock's 52 week high is $293.81 per share and its 52 week low is $190.4. With average free cash flows of $849.07 Million that have been growing at an average rate of 19.9% over the last 5 years, ResMed declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2025 | 1,751,588 | 89,865 | 1,661,723 | 27.65 |
| 2024 | 1,401,260 | 99,460 | 1,301,800 | 126.94 |
| 2023 | 693,299 | 119,672 | 573,627 | 165.19 |
| 2022 | 351,147 | 134,835 | 216,312 | -65.88 |
| 2021 | 736,718 | 102,712 | 634,006 | -10.31 |
| 2020 | 802,255 | 95,330 | 706,925 |
